+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bovine Tuberculosis Diagnosis Market by Test Type, Product, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011093
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bovine Tuberculosis Diagnosis Market grew from USD 887.85 million in 2024 to USD 960.80 million in 2025. It is expected to continue growing at a CAGR of 7.83%, reaching USD 1.39 billion by 2030.

Unveiling the Critical Need for Advanced Bovine Tuberculosis Diagnostics

Early detection of bovine tuberculosis has evolved into a nonnegotiable pillar of herd health management and agricultural resilience. Outbreaks of Mycobacterium bovis in cattle herds not only threaten animal well-being but also incur substantial economic burdens through livestock losses, trade restrictions and public health liabilities. As governments tighten biosecurity protocols and consumers demand enhanced food safety, the urgency for diagnostics that deliver rapid, precise and scalable results has reached an all-time high. Over the past decade, diagnostic technologies have migrated from conventional skin testing to integrated laboratory platforms combining immunoassays, molecular amplification techniques and digital data analytics.

The market now showcases a spectrum of methodologies ranging from intradermal skin assays to sophisticated polymerase chain reaction systems, each with distinct operational benefits and limitations. This diversity reflects an industry in transition, where sensitivity thresholds, throughput requirements and cost considerations must be balanced against field feasibility and regulatory compliance. Meanwhile, cross-sector collaborations between research institutions, veterinary services and diagnostic developers are accelerating the translation of novel biomarkers into deployable assays. Such partnerships underscore the importance of agility in product development and the capacity to align innovations with real-world disease control programs.

As diagnostic strategies diversify, market analysis examines multiple test categories including intradermal assays subdivided into comparative intradermal cervical and single intradermal cervical formats alongside Elisa-based immunoassays, cytokine release tests and molecular diagnostics. This executive summary synthesizes emerging trends across different test formats, product categories and end-user segments to equip decision-makers with actionable insights.

Emerging Innovations and Paradigm Shifts Driving Diagnostic Evolution

The bovine tuberculosis diagnostics landscape is undergoing transformative change driven by breakthroughs in molecular biology and data integration. Molecular amplification techniques such as polymerase chain reaction have redefined sensitivity benchmarks by enabling pathogen detection at minimal concentrations, thereby reducing the window between infection onset and diagnosis. Concurrently, advanced immunological assays, including Elisa and gamma interferon testing, now benefit from enhanced reagent specificity and automated readers that optimize throughput for large-scale screening initiatives. These technological enhancements address longstanding limitations in traditional methods, offering rapid turnaround and improved accuracy.

Beyond core assay improvements, digital innovations are reshaping how diagnostic data are managed and interpreted. Cloud-based analytics platforms permit real-time aggregation of test results across veterinary clinics and central laboratories, facilitating early outbreak detection and trend analysis. Artificial intelligence algorithms further enhance interpretive consistency by minimizing user variability, particularly in colorimetric and fluorescence-based readouts. Such integration of AI with conventional diagnostic workflows heralds a new era of predictive disease surveillance.

This period of innovation coincides with evolving regulatory frameworks that increasingly prioritize standardized performance criteria and data interoperability. Harmonized guidelines from international animal health authorities are driving convergence in test validation requirements, thereby streamlining approval processes for next-generation assays. Together, these shifts are recalibrating industry priorities, compelling stakeholders to invest in flexible platforms capable of embracing both current needs and future diagnostic frontiers.

Assessing the Ripple Effects of US Tariffs on Veterinary Diagnostics

The imposition of new tariffs by the United States government in early 2025 has introduced a significant variable into the global supply chain for bovine tuberculosis diagnostics. Imported reagents, instrument components and specialized consumables now face elevated cost pressures, compelling domestic diagnostic companies to reevaluate sourcing strategies. As a result, prices of key molecular assay kits and immunodiagnostic reagents have experienced upward adjustments, affecting both centralized laboratories and on-farm testing programs. This escalation in operational expenses has prompted some providers to accelerate investments in local manufacturing capabilities, while others are exploring alternative suppliers in tariff-exempt jurisdictions.

Tariff-induced shifts have also influenced research and development trajectories. Companies are allocating resources toward reagent optimization and multiplexing techniques that can maximize data output per consumable unit, thereby offsetting higher unit costs. Collaborative ventures between instrument manufacturers and reagent developers have gained traction, aiming to create integrated platforms that deliver cost efficiencies and streamlined maintenance protocols. Furthermore, government agencies are increasingly funding public-private partnerships to bolster domestic production capacity and mitigate supply chain vulnerabilities.

The cumulative impact of these tariffs extends beyond immediate cost considerations, as price volatility influences end-user adoption rates and budget allocations across veterinary hospitals, diagnostic laboratories and governmental disease control programs. Maintaining diagnostic quality standards while navigating evolving trade policies will remain a critical challenge for stakeholders throughout 2025 and beyond.

Deep Dive into Test Types Products and User Segments Shaping the Market

A robust understanding of market segmentation illuminates the nuanced dynamics guiding bovine tuberculosis diagnostics adoption. Test type analysis highlights a foundational role for intradermal assays, notably the Caudal Fold Test, which itself bifurcates into comparative intradermal cervical and single intradermal cervical formats. These traditional skin tests continue to serve as primary screening tools in regions with established veterinary practices. Parallel to these methods, Elisa assays offer high-throughput immunoassay capabilities, while gamma interferon assays introduce cytokine-based sensitivity enhancements appropriate for confirmatory testing. At the forefront of molecular innovation, polymerase chain reaction platforms enable direct pathogen detection, dramatically reducing turnaround times and elevating diagnostic specificity.

Product segmentation further differentiates the market through distinct instrument, kit and reagent portfolios. Instrumentation ranges from dedicated Elisa readers to advanced PCR machines, each tailored to laboratory throughput requirements. Kit offerings include formats specific to each testing methodology-Caudal Fold Test Kits, Elisa Kits, Gamma Interferon Assay Kits and PCR Kits-ensuring compatibility with established protocols. Supporting these platforms, reagents such as antigens and enzymes form the biochemical core of immunoassays, while primers and probes drive the sensitivity of nucleic acid tests, themselves subdivided into primer and probe sets optimized for Mycobacterium bovis sequences.

End-user segmentation underscores application diversity, encompassing diagnostic laboratories where high-volume testing predominates, government agencies overseeing large-scale screening initiatives, research institutes focused on assay development and veterinary hospitals delivering point-of-care services. Each category exhibits unique operational priorities, funding structures and regulatory obligations, collectively shaping market demand and innovation pathways.

Regional Dynamics Highlight Diverse Diagnostic Demands across Key Markets

Regional analysis reveals distinct diagnostic imperatives and adoption trajectories across global markets. In the Americas, longstanding bovine tuberculosis control programs leverage a combination of intradermal screening and confirmatory molecular assays. Extensive federal funding in North America supports expansive surveillance networks, while Latin American initiatives emphasize capacity building through public-private partnerships. This blend of policy support and technological investment sustains steady demand for both high-volume Elisa readers and point-of-care skin testing kits.

The Europe, Middle East & Africa region presents a regulatory mosaic where the European Union’s stringent animal health standards drive widespread adoption of validated immunoassays and molecular diagnostics. Member states routinely integrate gamma interferon assays into national eradication protocols, complementing intradermal tests with laboratory-based confirmatory workflows. In Middle Eastern and African markets, infrastructure constraints have historically limited access to advanced platforms, but targeted donor programs and mobile laboratory units are expanding diagnostic reach, particularly in transboundary disease hotspots.

Across Asia-Pacific, rapid economic development and growing dairy industries are fueling investment in both centralized and decentralized testing solutions. Countries with established veterinary research institutes frequently deploy PCR machines for pathogen surveillance, while emerging economies prioritize cost-effective skin tests to manage outbreaks at the herd level. Collaborative government initiatives with research entities are accelerating validation of novel assays adapted to local cattle breeds and epidemiological conditions. These region-specific dynamics underscore the importance of tailored diagnostic strategies to address diverse epidemiological landscapes.

Leading Industry Players Driving Breakthroughs and Strategic Collaborations

Major diagnostic manufacturers are shaping the bovine tuberculosis market through targeted research investments and strategic alliances. Thermo Fisher Scientific, leveraging its molecular biology portfolio, has expanded its PCR platform offerings with Mycobacterium-specific primer and probe kits optimized for field and laboratory applications. Zoetis builds upon its veterinary reagent expertise by enhancing gamma interferon assay sensitivity and integrating digital data capture into its immunoassay workflows. IDEXX Laboratories focuses on automating Elisa processes through advanced reader systems that feature real-time quality controls and user-friendly interfaces designed for diagnostic laboratories of varying scales.

Collaborations between instrument vendors and reagent developers are increasingly common. For example, partnerships aimed at co-developing integrated assay systems have reduced time-to-market for multiplex testing kits, while joint ventures with regional manufacturers ensure compliance with local regulations and supply chain resilience. Biomerieux’s acquisition strategy, targeting niche reagent providers and specialty assay startups, exemplifies consolidation efforts intended to broaden product portfolios and accelerate entry into emerging markets. Merck Animal Health leverages its global distribution network to introduce next-generation skin test antigens with improved specificity, collaborating with governmental agencies to align assay validation with national eradication programs.

Collectively, these leading players drive competitive differentiation through technological innovation, geographical expansion and value-added services, setting the pace for future advances in bovine tuberculosis diagnostics.

Strategic Imperatives for Stakeholders to Capitalize on Market Opportunities

Industry leaders must adopt a multi-pronged approach to maximize impact in the evolving bovine tuberculosis diagnostics market. Prioritizing modular molecular platforms capable of accommodating both current assay chemistries and future biomarker developments allows organizations to maintain agility in response to emerging strains and regulatory updates. Simultaneously, investment in localized manufacturing can buffer against tariff-induced volatility and ensure steady access to critical reagents and kits. Strengthening collaborative frameworks with research institutes and public health agencies fosters co-development of assays tailored to region-specific epidemiological profiles, enhancing adoption rates and reinforcing surveillance networks.

Digital integration represents another critical frontier. Companies should allocate resources toward cloud-based data management systems that offer real-time visibility into testing outcomes, enabling stakeholders to detect and contain outbreaks swiftly. Embedding artificial intelligence algorithms within analytic pipelines not only improves interpretive consistency across decentralized testing sites but also generates predictive insights that inform pre-emptive intervention strategies.

Finally, building capacity through end-user training and technical support is essential for sustained market growth. Customized educational programs for veterinary practitioners and laboratory technicians enhance assay performance and data reliability, ultimately validating the efficacy of diagnostic solutions. By orchestrating these strategic imperatives-flexible technology platforms, robust supply chains, digital analytics and targeted training-stakeholders can unlock new value streams and fortify bovine tuberculosis control efforts on a global scale.

Rigorous Research Methodology Ensuring Comprehensive Market Analysis

The insights presented in this executive summary stem from a rigorous research methodology combining qualitative and quantitative approaches. Secondary research entailed an exhaustive review of scientific literature, regulatory filings, industry announcements and patent databases to map technological advancements and competitive activity in bovine tuberculosis diagnostics. Primary research involved structured interviews with key opinion leaders, including veterinary epidemiologists, laboratory directors and policy makers overseeing national bovine tuberculosis eradication programs. These dialogues provided first-hand perspectives on unmet needs, procurement criteria and operational challenges across regions.

Data triangulation was applied to reconcile findings from disparate sources, ensuring consistency and reliability. Market segmentation analysis segmented the diagnostic landscape by test type, product category and end-user application, offering granular visibility into performance indicators across diverse methodologies. Regional analysis leveraged epidemiological data and trade statistics to contextualize diagnostic demand within local disease prevalence and regulatory frameworks. Competitive profiling assessed leading and emerging players based on product pipelines, strategic partnerships and market positioning.

Quality checks, including peer reviews and data validation protocols, bolstered the accuracy of insights. All findings were synthesized to generate actionable recommendations, mindful of evolving trade policies and technological frontiers. This methodological framework underpins a comprehensive and balanced market analysis, equipping decision-makers with the intelligence required to navigate complex diagnostic ecosystems.

Synthesis of Insights to Inform Future Directions in Diagnostic Solutions

The convergence of advanced molecular techniques, automation and digital analytics is redefining the boundaries of bovine tuberculosis diagnostics. Emerging assay formats, ranging from optimized skin test kits to high-throughput PCR platforms, address the dual imperatives of sensitivity and operational scalability. Regional market dynamics-from the Americas’ well-funded eradication programs to Asia-Pacific’s rapidly expanding dairy industries-underscore the necessity of adaptable diagnostic solutions tailored to local epidemiological and infrastructural contexts.

Tariff-driven supply chain shifts have highlighted the critical importance of localized manufacturing capabilities and reagent optimization strategies. Meanwhile, partnerships between instrument developers and reagent specialists have accelerated integrated system deployments, reducing barriers to adoption in both centralized laboratories and field environments. As regulatory frameworks coalesce around standardized validation criteria, stakeholders benefit from clearer pathways for assay approval and market entry.

Taken together, these trends point toward a future in which diagnostics will not only detect pathogens but also leverage predictive analytics to anticipate outbreak risks. Stakeholders who embrace flexible technology platforms, invest in digital infrastructure and cultivate end-user expertise will be best positioned to lead the next wave of innovation. The ongoing interplay between scientific discovery, policy evolution and commercial strategy will continue to shape the trajectory of bovine tuberculosis management, offering pathways to more effective disease control and enhanced animal health worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Caudal Fold Test
      • Comparative Intradermal Cervical Test
      • Single Intradermal Cervical Test
    • Elisa
    • Gamma Interferon Assay
    • PCR
  • Product
    • Instruments
      • Elisa Readers
      • Pcr Machines
    • Kits
      • Caudal Fold Test Kits
      • Elisa Kits
      • Gamma Interferon Assay Kits
      • PCR Kits
    • Reagents
      • Antigens
      • Enzymes
      • Primers And Probes
        • Primers
        • Probes
  • End User
    • Diagnostic Laboratories
    • Government Agencies
    • Research Institutes
    • Veterinary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • HIPRA S.A.
  • Elanco Animal Health Incorporated
  • Biogal-Galed Laboratories Ltd.
  • VMRD, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bovine Tuberculosis Diagnosis Market, by Test Type
8.1. Introduction
8.2. Caudal Fold Test
8.2.1. Comparative Intradermal Cervical Test
8.2.2. Single Intradermal Cervical Test
8.3. Elisa
8.4. Gamma Interferon Assay
8.5. PCR
9. Bovine Tuberculosis Diagnosis Market, by Product
9.1. Introduction
9.2. Instruments
9.2.1. Elisa Readers
9.2.2. Pcr Machines
9.3. Kits
9.3.1. Caudal Fold Test Kits
9.3.2. Elisa Kits
9.3.3. Gamma Interferon Assay Kits
9.3.4. PCR Kits
9.4. Reagents
9.4.1. Antigens
9.4.2. Enzymes
9.4.3. Primers And Probes
9.4.3.1. Primers
9.4.3.2. Probes
10. Bovine Tuberculosis Diagnosis Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Government Agencies
10.4. Research Institutes
10.5. Veterinary Hospitals
11. Americas Bovine Tuberculosis Diagnosis Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Bovine Tuberculosis Diagnosis Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Bovine Tuberculosis Diagnosis Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Thermo Fisher Scientific Inc.
14.3.2. Zoetis Inc.
14.3.3. IDEXX Laboratories, Inc.
14.3.4. Bio-Rad Laboratories, Inc.
14.3.5. Merck & Co., Inc.
14.3.6. Neogen Corporation
14.3.7. HIPRA S.A.
14.3.8. Elanco Animal Health Incorporated
14.3.9. Biogal-Galed Laboratories Ltd.
14.3.10. VMRD, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET MULTI-CURRENCY
FIGURE 2. BOVINE TUBERCULOSIS DIAGNOSIS MARKET MULTI-LANGUAGE
FIGURE 3. BOVINE TUBERCULOSIS DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COMPARATIVE INTRADERMAL CERVICAL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SINGLE INTRADERMAL CERVICAL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GAMMA INTERFERON ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ELISA READERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PCR MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GAMMA INTERFERON ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ANTIGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 58. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 60. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 61. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 62. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 63. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 107. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 111. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 112. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 120. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 131. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 133. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 134. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 135. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 136. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 139. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 143. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 144. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 176. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 187. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 190. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 192. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 200. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 224. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 231. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 232. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 248. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 250. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 251. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 253. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 254. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 255. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 256. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 274. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 276. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 278. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 279. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 280. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 281. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 284. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 287. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 288. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 289. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 297. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIMERS AND PROBES, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABL

Companies Mentioned

The companies profiled in this Bovine Tuberculosis Diagnosis market report include:
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • HIPRA S.A.
  • Elanco Animal Health Incorporated
  • Biogal-Galed Laboratories Ltd.
  • VMRD, Inc.

Methodology

Loading
LOADING...

Table Information